2005
DOI: 10.1016/j.jconrel.2005.08.017
|View full text |Cite
|
Sign up to set email alerts
|

Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

12
371
0
10

Year Published

2009
2009
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 496 publications
(394 citation statements)
references
References 21 publications
12
371
0
10
Order By: Relevance
“…15,16 Unfortunately, the instability of the underlying surface to aqueous environments has hindered the wide-scale employment of PSi for biological applications. 17,18 Recent interest in PSi was focused on its use as a delivery vehicle for therapeutic agents such as ibuprofen 19 and insulin. 20 Central to the use of PSi as an effective drug delivery system is the need to find balance between passivation of the highly reactive native Si-H x surface species to minimize damage to the loaded molecule and control the release of the drug by erosion of the PSi matrix.…”
Section: Introductionmentioning
confidence: 99%
“…15,16 Unfortunately, the instability of the underlying surface to aqueous environments has hindered the wide-scale employment of PSi for biological applications. 17,18 Recent interest in PSi was focused on its use as a delivery vehicle for therapeutic agents such as ibuprofen 19 and insulin. 20 Central to the use of PSi as an effective drug delivery system is the need to find balance between passivation of the highly reactive native Si-H x surface species to minimize damage to the loaded molecule and control the release of the drug by erosion of the PSi matrix.…”
Section: Introductionmentioning
confidence: 99%
“…11 Drug and peptide delivery by PSi particles has already been demonstrated and with promising results. 12,13 PSi particles can be loaded with diverse payloads, such as small molecule drugs and peptides. In addition, improved solubility of poorly soluble drugs after loading has been reported.…”
mentioning
confidence: 99%
“…Elemental and molecular information were used to study their distributions in the porous region and the chemistry of their adsorption. Methylene blue (MW ϭ 284 Da) [4], and the delivery of active pharmaceutical ingredients [5,6]. The ongoing interest in pSi for use as a therapeutic delivery system is due to the large internal surface area available, the readily modified surface chemistry [7] and, in particular, the excellent in vivo biodegradation and biocompatibility (low toxicity) of the silicon substrate, hydrolysing to form orthosilicic acid, which is readily excreted [8].…”
mentioning
confidence: 99%
“…Negative fragments (SiOSH 3 Ϫ and SiO 2 SCH -) also suggested chemisorption via O bridging of the substrate Si and methylene blue S. The larger Papain molecule (23,406 Da) distributed itself in a similar manner to methylene blue demonstrating larger molecules can be effectively incorporated into such pore structures. (J Am Soc Mass Spectrom 2010, 21, 254 -260) © 2010 American Society for Mass Spectrometry P orous silicon (pSi) is a nanostructured material with 2-50 nm pores and has been investigated for use in a range of applications, including; optical [1,2], biosensing [3], radiotherapy (brachytherapy) [4], and the delivery of active pharmaceutical ingredients [5,6]. The ongoing interest in pSi for use as a therapeutic delivery system is due to the large internal surface area available, the readily modified surface chemistry [7] and, in particular, the excellent in vivo biodegradation and biocompatibility (low toxicity) of the silicon substrate, hydrolysing to form orthosilicic acid, which is readily excreted [8].…”
mentioning
confidence: 99%